Novartis Pharmaceuticals Corp. recalls Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New J
Recalled May 29, 2019 · FDA recall D-1309-2019 · Novartis Pharmaceuticals
Hazard
Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour. · FDA Class I
Units
792 cartons
Sold at
Nationwide with in the United States
Description
Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.
Product
Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981 Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936 Product of Ireland, NDC 0078-0972-61.
Manufacturer(s)
Novartis Pharmaceuticals Corp.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →